Effect of Cyclosporine and Remote Ischemic Preconditioning in Reperfusion Ischemia Injury on Tetralogy Fallot Patients With Correction Surgery
Myocardial Injury, Cardiac Surgery
About this trial
This is an interventional treatment trial for Myocardial Injury focused on measuring RIPC, cyclosporine, ischemia reperfusion injury, MDA, calcium cytosol, tetralogy Fallot, mitochondrial edema, infundibulum
Eligibility Criteria
Inclusion Criteria: Tetralogy Fallot patient that is undergoing correction surgery Has an ideal anatomy for corrective surgery, namely: Pulmonary artery size within normal limits (according to the kirklin table), Mc Goon ratio> 1.5, Nakata index> 200, normal coronary artery ostium and good biventricular function. Exclusion Criteria: Patient refuses the procedure Patient with acute kidney injury Patient without lower extremity Patient with cyclosporin allergy
Sites / Locations
- Indonesia University
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Cyclosporin + RIPC
Control
This group received cyclosporin intravenously 2 hours pre-induction of anesthesia, with the dose of 3 mg/ kg body weight. RIPC was performed preoperatively after induction of anesthesia by inflating pressure cuff on the extremity 30 mmHg higher than systolic blood pressure of the patient for 5x5 minutes with 5 minutes reperfusion interval.
This group received placebo intravenously 2 hours pre-induction of anesthesia.